iShares US Pharmaceuticals ETF
IHE
IHE
112 hedge funds and large institutions have $104M invested in iShares US Pharmaceuticals ETF in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 30 increasing their positions, 25 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.24% less ownership
Funds ownership: 78.45% → 78.21% (-0.24%)
Holders
112
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.44M | |
| 2 | +$1.52M | |
| 3 | +$1.13M | |
| 4 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$878K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$878K |
Top Sellers
| 1 | -$7.63M | |
| 2 | -$1.76M | |
| 3 | -$643K | |
| 4 |
Goldman Sachs
New York
|
-$556K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$373K |